The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Outbreak of Ebola Virus Disease in Guinea: Where Ecology Meets Economy
Open accessAbstract
Ebola virus is back, this time in West Africa, with over 350 cases and a 69% case fatality ratio at the time of this writing [1]. The culprit is the Zaire ebolavirus species, the most lethal Ebola virus known, with case fatality ratios up to 90%. The epicenter and site of first introduction is the region of Gueckedou in Guinea’s remote southeastern forest region, spilling over into various other regions of Guinea as well as to neighboring Liberia and Sierra Leone (Figure 1). News of this outbreak engenders three basic questions: (1) What in the world is Zaire ebolavirus doing in West Africa, far from its usual haunts in Central Africa? (2) Why Guinea, where no Ebola virus has ever been seen before? (3) Why now? We’ll have to wait for the outbreak to conclude and more data analysis to occur to answer these questions in detail, and even then we may never know, but some educated speculation may be illustrative. The Ebolavirus genus is comprised of five species, Zaire, Sudan, Tai Forest, Bundibugyo, and Reston, each associated with a consistent case fatality and more or less well-identified endemic area (Figure 2). Zaire ebolavirus had been previously found only in three Central African countries—the Democratic Republic of the Congo, Republic of the Congo, and Gabon. Thus, the logical assumption when Ebola virus turned up in Guinea was that this would be the Tai Forest species previously noted in Guinea’s neighbor, Cote d’Ivoire. How did Zaire ebolavirus get all the way over to West Africa? The two possibilities appear to be that the virus has always been present the region, but we just never noticed, or that it was recently introduced. The initial report and phylogenetic analyses on the Guinea outbreak suggested that the Zaire ebolavirus found in Guinea is a distinct strain from that noted in Central Africa [1], thus suggesting that the virus may not be a newcomer to the region. However, subsequent reworking and interpretations of the limited genetic data have cast some doubt on this conclusion [2]. If Zaire ebolavirus had been circulating for some time in Guinea, one might expect greater sequence variation than the 97% homogeneity noted relative to that isolated from Central Africa [1]. Phylogenetic arguments aside, if Ebola virus was present in Guinea, wouldn’t we have seen cases before? Not necessarily. Many pathogens may be maintained in animals with which humans normally have little contact, thus providing limited opportunity for infection. Furthermore, the proportion of infected animals may often be very low, so even frequent contact may not result in pathogen transmission. Even if human Ebola virus infection has occurred, it may not be recognized; contrary to popular concept, the clinical presentation of viral hemorrhagic fever is often very nonspecific, with frank bleeding seen in a minority of cases, so cases may be mistaken for other, more common diseases or, in the case of Guinea, Lassa fever, which is endemic in the area of the outbreak [3]. Nor are laboratory diagnostics routinely available in West Africa for most viral hemorrhagic fevers [4]. Ebola virus testing of human serum samples collected as far back as 1996 as part of surveillance for Lassa fever in the same region as the current outbreak could help reveal whether humans had exposure to Ebola virus prior to this outbreak [3]. We are presently organizing with collaborators to conduct ELISA antigen testing, PCR, and cell culture for Ebola virus on samples from persons who met the case definition for viral hemorrhagic fever but tested negative for Lassa fever. We will also test all samples for IgG antibody to Ebola virus to explore the prevalence of past exposure. Could Zaire ebolavirus have been recently introduced into Guinea from Central Africa? Introduction from a human traveler seems unlikely; there is little regular travel or trade between Central Africa and Guinea, and Gueckedou, the remote epicenter and presumed area of first introduction, is far off the beaten path, a minimum 12 hour drive over rough roads from the capitals of Guinea, Liberia, or Sierra Leone (Figure 1). Furthermore, with the average incubation period as well as time from disease onset until death in fatal cases both a little over a week, a human traveler would have to make the trip from Central Africa to Gueckedou rather rapidly. If Ebola virus was introduced into Guinea from afar, the more likely traveler was a bat. Although a virus has not yet been isolated, PCR and serologic evidence accumulated over the past decade suggests that fruit bats are the likely reservoir for Ebola virus. The hammer-headed fruit bat (Hypsignathus monstrosus), Franquet’s epauletted fruit bat (Epomops franqueti), and the little collared fruit bat (Myonycteris torquata) are among the leading candidates [5–9]. Many of these species are common across sub-Saharan Africa, including in Guinea, and/or may migrate long distances, raising the possibility that one of these wayward flyers may have c
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fruit bats as reservoirs of Ebola virus
Leroy, E. M., Kumulungui, B., Pourrut, X., Rouquet, P., Hassanin, A., Yaba, P., Délicat, A., Paweska, J. T., Gonzalez, J.-P., & Swanepoel, R. (2005) · Nature · doi:10.1038/438575a · Cited by 1,606
Emergence of Zaire Ebola Virus Disease in Guinea
Baize, S., Pannetier, D., Oestereich, L., Rieger, T., Koivogui, L., Magassouba, N., Soropogui, B., Sow, M. S., Keïta, S., De Clerck, H., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404505 · Cited by 1,366
Multiple Ebola Virus Transmission Events and Rapid Decline of Central African Wildlife
Leroy, E. M., Rouquet, P., Formenty, P., Souquière, S., Kilbourne, A., Froment, J.-M., Bermejo, M., Smit, S., Karesh, W., Swanepoel, R., et al. (2004) · Science · doi:10.1126/science.1092528 · Cited by 794
Leroy, E. M., Epelboin, A., Mondonge, V., Pourrut, X., Gonzalez, J.-P., Muyembe-Tamfum, J.-J., & Formenty, P. (2009) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2008.0167 · Cited by 562
Ebola Outbreak Killed 5000 Gorillas
Bermejo, M., Rodríguez-Teijeiro, J. D., Illera, G., Barroso, A., Vilà, C., & Walsh, P. D. (2006) · Science · doi:10.1126/science.1133105 · Cited by 407
Pourrut, X., Souris, M., Towner, J. S., Rollin, P. E., Nichol, S. T., Gonzalez, J.-P., & Leroy, E. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-159 · Cited by 312
New opportunities for field research on the pathogenesis and treatment of Lassa fever
Khan, S. H., Goba, A., Chu, M., Roth, C., Healing, T., Marx, A., Fair, J., Guttieri, M. C., Ferro, P., Imes, T., et al. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2007.11.003 · Cited by 189
Self-citationPourrut, X., Délicat, A., Rollin, P. E., Ksiazek, T. G., Gonzalez, J. ‐., & Leroy, E. M. (2007) · The Journal of Infectious Diseases · doi:10.1086/520541 · Cited by 187
TRIGGER EVENTS: ENVIROCLIMATIC COUPLING OF EBOLA HEMORRHAGIC FEVER OUTBREAKS
Pinzón, J. E. D., WILSON, J. M., Tucker, C. J., Arthur, R. R., Jahrling, P. B., & Formenty, P. B. H. (2004) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.71.664 · Cited by 128
Lahm, S. A., Kombila, M., Swanepoel, R., & Barnes, R. F. W. (2006) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2006.07.002 · Cited by 104
Phylogenetic Analysis of Guinea 2014 EBOV Ebolavirus Outbreak
Dudas, G., & Rambaut, A. (2014) · PLoS Currents · doi:10.1371/currents.outbreaks.84eefe5ce43ec9dc0bf0670f7b8b417d · Cited by 89
Jeźek, Z., Szczeniowski, M. Y., Muyembe‐Tamfum, J. J., McCormick, J. B., & Heymann, D. L. (1999) · The Journal of Infectious Diseases · doi:10.1086/514295 · Cited by 39
Bertherat, E., Talarmin, A., & Zeller, H. G. (1999) · PubMed · Cited by 37
Deuffic‐Burban, S., Lenne, X., Dervaux, B., Poissy, J., Lemaire, X., Sloan, C. E., Carrat, F., Desenclos, J. C., Delfraissy, J., & Yazdanpanah, Y. (2009) · PLoS Currents · doi:10.1371/currents.rrn1121 · Cited by 13
Bausch, D. G., & Rollin, P. E. (2014) · ASM Press eBooks · doi:10.1128/9781555816995.ch4 · Cited by 12
Self-citation
Cited by
Whitmee, S., Haines, A., Beyrer, C., Boltz, F., Capon, A. G., de Souza Dias, B. F., Ezeh, A., Frumkin, H., Gong, P., Head, P., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60901-1 · Cited by 2,998
Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone
Schieffelin, J. S., Shaffer, J. G., Goba, A., Gbakie, M., Gire, S. K., Colubri, A., Sealfon, R. S. G., Kanneh, L., Moigboi, A., Momoh, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1411680 · Cited by 530
Self-citationPost-pandemic transformations: How and why COVID-19 requires us to rethink development
Leach, M., MacGregor, H., Scoones, I., & Wilkinson, A. (2021) · World Development · doi:10.1016/j.worlddev.2020.105233 · Cited by 481
Transmission dynamics and control of Ebola virus disease (EVD): a review
Chowell, G., & Nishiura, H. (2014) · BMC Medicine · doi:10.1186/s12916-014-0196-0 · Cited by 411
Mapping the zoonotic niche of Ebola virus disease in Africa
Pigott, D. M., Golding, N., Mylne, A., Huang, Z., Henry, A. J., Weiss, D. J., Brady, O. J., Kraemer, M. U., Smith, D. L., Moyes, C. L., et al. (2014) · eLife · doi:10.7554/elife.04395 · Cited by 405
Metadata
- Authors
- Bausch, D. G., & Schwarz, L.
- Venue
- PLoS Neglected Tropical Diseases
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-07-31
- Volume
- 8
- Issue
- 7
- Pages
- e3056
- ISSN
- 1935-2727 (ISSN-L)
- 1935-2735
- OpenAlex
- W1978700210
- Cited by
- 287
- References
- 15
- FWCI
- 37.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.